| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2000104 | 精蛋白重组人胰岛素混合注射液（50R） | human insulin;isophane protamine human insulin | Injection | Biological Products(15) | New Drug Application | 2020-05-18 | 吉林惠升生物制药有限公司 | Jilin Huisheng Biopharmaceutical Co Ltd | In Review | 2020-05-15 | view |